Newsroom

Adjuvant Imatinib Study Updates Results

A recent study further documented the advantage of three years of adjuvant imatinib versus one year in high-risk GIST patients. The study, which is to be published in the Journal of Clinical Oncology, was authored by [...]

By |2018-10-30T13:56:09-04:00December 16th, 2015|Gleevec, News, Newsletter, Research, Survival Strategies|

Henzo Kenya Holds Psychological Support and Wellness Conference

Henzo Kenya,  the CML and GIST support organization in Kenya, Africa held a conference at the Nairobi Hospital in the New Lecture Theatre Hall on Psychological Support and Wellness [...]

By |2020-09-18T11:02:16-04:00November 3rd, 2015|Events, GIST Education, News, Patient Support|

Rol de los Hallazgos Histopatologicos y del Analisis Molecular en el Tratamiento del GIST

Rol de los Hallazgos Histopatologicos y del Analisis Molecular en el Tratamiento del GIST presentación del Monica Garcia-Buitrago, October 30, 2015.

By |2020-07-09T15:03:08-04:00October 30th, 2015|GIST Education, Global, Video|

Mechanisms of Disease Persistence in Gastrointestinal Stromal Tumors

By Tamas Ordog, LRG Research Team, Martin Zörnig and Yujiro Hayashi Dr. Tamas Ordog Gastrointestinal stromal tumors (GIST) represent a substantial proportion of human bone and soft tissue sarcomas.1 GIST are thought [...]

By |2019-10-31T12:01:09-04:00October 16th, 2015|News, Research|

GIST Pathology Report: The Key to Understanding Your GIST

After the diagnosis of GIST, a patient should take important steps to learn more about their particular disease so that they may find optimal care and treatment. This can be a very challenging and sometimes overwhelming task. Getting a copy of the surgical pathology report is one of those steps.

By |2026-01-11T15:47:43-05:00October 16th, 2015|News, Patient Support|
Go to Top